Watson challenges Takeda's Rozerem patent
AP - 1 hour 2 minutes agoWatson Pharmaceuticals Inc. said Friday it is challenging Takeda Pharmaceutical Co.'s patent on the insomnia treatment Rozerem.
4786 Stories, most recent news story added 48 minutes ago
Watson Pharmaceuticals Inc. said Friday it is challenging Takeda Pharmaceutical Co.'s patent on the insomnia treatment Rozerem.
SAN DIEGO----Absorption Systems, a leader in testing drugs for ADMET , today introduced an extensively renovated surgical suite for preclinical medical device testing at the company’s facility in San Diego, CA.
In other swine flu news, CDC warns of H1N1 E-mail phishing scam.
Shares of Cubist Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying he believes Cubist will successfully defend the patents on its antibiotic Cubicin, and expects sales will remain strong. Jason Kantor of RBC Capital Markets... Stock - Business - Investing - Biotechnology and Pharmaceuticals - Pharmaceuticals
In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment.
WESTMINSTER, Colo.----Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ outside of the United States.
(ARA) - Having a good hair day could mean spending money on salon appointments and several products to look as good as you did when you left the salon.
As medical director for SSM St. Joseph Hospital West, the health and wellness of our community is of great interest to me.
Administration of propofol by nonanesthesiologists is safe; proper training and patient selection are crucialThe worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is ...
Cancer Epidemiology, Biomarkers & Prevention to offer best research practices related to tobacco useThe study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP ...
An economist at the Office of Management and Budget who has battled environmentalists for years on issues such as climate change and smog has raised questions about the economic impact of a proposed new rule on air pollution, according to documents obtained by The Washington Post.
Despite the FDA's recent rejection of experimental drug Ampligen, Hemispherx's CEO remains optimistic.
Watson Pharmaceuticals Inc. said Friday it is challenging Takeda Pharmaceutical Co.'s patent on the insomnia treatment Rozerem.
(AP:ST. PAUL, Minn.) Medical device maker St. Jude Medical Inc. said Friday the Food and Drug Administration approved a new neurostimulation device aimed at treating pain.
Dec. 4 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in U.K. and Irish markets today. Stock symbols are in parentheses and prices are from the last market close.
Dec. 4 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in U.K. and Irish markets today. Stock symbols are in parentheses and prices are from the last market close.